close
close

Guiltandivy

Source for News

    • LILLY DRN

    Why Eli Lilly's Zepbound and Mounjaro sales lagged
    Update Information

    Why Eli Lilly's Zepbound and Mounjaro sales lagged

    Eli Lilly'Blockbuster weight-loss drug Zepbound and diabetes drug Mounjaro posted weaker-than-expected sales in the third quarter, although supply of both drugs has largely recovered from widespread shortages in the United States According to the company, the reason is not a…

    Posted on Kathleen William
    Jim Cramer on Eli Lilly, AMD shares after their big earnings drops
    Update Information

    Jim Cramer on Eli Lilly, AMD shares after their big earnings drops

    Every weekday, CNBC Investing Club hosts a “Morning Meeting” livestream with Jim Cramer at 10:20 a.m. ET. Here's a recap of Wednesday's key moments. 1. Stocks were higher on Wednesday as big technology companies delivered gains and bond yields remained…

    Posted on Kathleen William
    Eli Lilly (LLY) Q3 2024 results
    Update Information

    Eli Lilly (LLY) Q3 2024 results

    The Lilly Biotechnology Center is shown on March 1, 2023 in San Diego, California, USA. Mike Blake | Reuters Eli Lilly on Wednesday fell short of third-quarter profit and sales expectations, weighed down by disappointing sales of its blockbuster weight-loss…

    Posted on Kathleen William

    ads